Trials / Unknown
UnknownNCT05781880
Normobaric Hyperoxia Stabilizing Ischemic Penumbra
Efficiency and Safety Evaluation of Normobaric Hyperoxia Stabilizing the Penumbra in Patients With Acute Ischemic Stroke
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- Sponsor
- Ji Xunming,MD,PhD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and efficacy of normobaric hyperoxia (NBO) stabilizing penumbra in acute ischemic stroke patients.
Detailed description
All the enrolled patients were randomly assigned to NBO and control group. NBO group will be given 100% oxygen ( (10L/min for 4h) via a storage oxygen face mask and control group will be given oxygen using nasal oxygen(2L/min for 4h) .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oxygen 100% | NBO therapy were given 100% oxygen via a face mask (10L/min for 4h) |
Timeline
- Start date
- 2023-03-22
- Primary completion
- 2024-11-30
- Completion
- 2024-12-31
- First posted
- 2023-03-23
- Last updated
- 2023-04-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05781880. Inclusion in this directory is not an endorsement.